ARTICLE | Company News
Gilead, GlaxoSmithKline sales and marketing update
December 7, 2009 8:00 AM UTC
The partners added commercialization rights in five Asian territories for Viread tenofovir to a 2002 deal under which GSK received exclusive rights to Gilead's HBV drug Hepsera adefovir in China, Ja...